Onchilles Pharma is a biotechnology company developing first-in-class biologics therapies for the treatment of cancer.
Onchilles Pharma is a biotechnology company developing first-in-class biologics therapies for the treatment of cancer. The company's drug selectively targets cancer cells and is non-toxic to normal cells and tissues, helping medical professionals treat cancer patients efficiently.It was founded in 2017 and is headquartered in San Diego, California.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jul 10, 2020 | Series A | $7M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
UChicago Startup Investment Program | — | Series A |